-
List item
CAR T-cell therapy registries
EMA's new workshop report describes the opportunities and challenges in using patient registries for the benefit-risk evaluations of chimeric antigen receptor (CAR) T-cell therapies.
-
List item
CAR T-cell therapy registries
EMA's new workshop report describes the opportunities and challenges in using patient registries for the benefit-risk evaluations of chimeric antigen receptor (CAR) T-cell therapies.
-
List item
Working for every patient in Europe
Our new video explains EMA's role in enabling timely patient access to new medicines in Europe. Watch the video now.
-
List item
Working for every patient in Europe
Our new video explains EMA's role in enabling timely patient access to new medicines in Europe. Watch the video now.
-
List item
Annual report
Read about EMA's key achievements and figures in 2017, including statistics on its regulatory procedures, activities, trends and changes in recent years.
-
List item
Annual report
Read about EMA's key achievements and figures in 2017, including statistics on its regulatory procedures, activities, trends and changes in recent years.
-
List item
European Immunization Week
EMA supports European Immunization Week from 23 to 29 April 2018. This World Health Organization initiative aims to increase vaccination coverage by raising awareness among parents and caregivers, health care professionals, policy and decision-makers, and the media.
-
List item
European Immunization Week
EMA supports European Immunization Week from 23 to 29 April 2018. This World Health Organization initiative aims to increase vaccination coverage by raising awareness among parents and caregivers, health care professionals, policy and decision-makers, and the media.
Latest news
-
List item
Updated measures for pregnancy prevention during retinoid use
Warning on possible risk of neuropsychiatric disorders also to be included for oral retinoids.
-
List item
Withdrawal of pain medicine flupirtine endorsed
Serious liver problems continued to be reported despite previous restrictions in use.
-
List item
Workshop on Paediatric Regulation – stakeholders to discuss how to boost development of medicines for children
Event to be broadcast live on 20 March.
-
List item
EMA Management Board: highlights of March 2018 meeting
Board adopts 2017 report on veterinary medicines for minor use minor species and hears update on clinical trial portal and database.
-
List item
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 March 2018
Immediate measures agreed for Zinbryta and Xofigo while reviews are ongoing; public hearing decided for quinolone and fluoroquinolone antibiotics.
-
List item
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 March 2018
Immediate measures agreed for Zinbryta and Xofigo while reviews are ongoing; public hearing decided for quinolone and fluoroquinolone antibiotics.
Information for
Key content
Services & databases
How does EMA work?
-
List item
How we regulate pharmaceutical research and development
-
List item
Our role in authorisation of medicines in the EU
-
List item
How the safety of medicines is monitored and controlled
-
List item
Who are EMAs scientific experts?
-
List item
Ensuring independence and transparency
-
List item
Another one